Day 1, Thursday, May 15th
08:00-09:30 Industry-supported Pre-COMy Symposium
09:30-09:40 Technical Break
09:40-09:50 COMy 2025 kick-off
09:50-11:20 Session 1: Advances in biology I
11:20-11:40 Coffee Break
11:40-13:10 Session 2: How do I assess?
13:10-13:40 Lunch Break
13:40-15:10 Industry-supported Lunch Symposium by J&J
15:10-15:20 Technical Break
15:20-16:20 Session 3: Advances in biology II
16:20-16:40 Coffee Break
16:40-18:10 Industry-supported Afternoon Symposium by Pfizer
18:10-18:20 Technical Break
18:20-19:00 Session 4: Plenary lectures I
19:00-19:30 Session 5: The COMy Debate: Treatment of smoldering myeloma
19:30 Welcome Reception
Day 2, Friday, May 16th
07:30-08:15 Industry-supported Breakfast Symposium by Oncopeptides
08:15-08:25 Technical Break
08:25-09:35 Session 6: How do I treat? Part I
09:35-09:55 Coffee Break
09:55-11:25 Industry-supported Morning Symposium by J&J
11:25-11:35 Technical Break
11:35-12:20 Session 7: IMS Session
12:20-12:50 Lunch Break
12:50-14:20 Industry-supported Lunch Symposium by Sanofi
14:20-14:30 Technical Break
14:30-15:15 Session 8: Next generation therapies
15:15-16:00 Session 9: Plenary lectures II
16:00-16:20 Coffee Break
16:20-17:50 Industry-supported Afternoon Symposium by BMS
17:50-18:00 Technical Break
18:00-19:00 Session 10: Treatment of relapsed/refractory disease
19:00-19:30 COMy Award Ceremony
Day 3, Saturday, May 17th
08:15-08:30 Good Morning Coffee
08:30-10:20 Session 11: The ideal trial on the road to achieve the best outcome for patients
10:20-10:35 Coffee Break continued …
10:35-11:50 Industry-supported Morning Symposium Adaptive
11:50-12:00 Technical Break
12:00-12:45 Session 12: Hot topics
12:45-13:15 Lunch Break
13:15-14:45 Industry-supported Lunch Symposium by GSK
14:45-14:55 Technical Break
14:55-16:10 Session 13: How do I treat? Part II
16:10-16:30 Coffee Break
16:30-18:00 Industry-supported Afternoon Symposium
18:00-18:10 Technical Break
18:10-19:15 Session 14: Keynote lectures
19:15-19:30 COMy In-Person Conclusions
Day 4, Sunday, May 18th – ONLINE ONLY
Multiple Myeloma Communications I
Virtual Industry Symposium
Multiple Myeloma Communications II
Virtual Industry Symposium
Final Panel Discussion and Conclusion